xylazine has been researched along with Autoimmune Diabetes in 1 studies
Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gordon, CS | 1 |
| Serino, AS | 1 |
| Krause, MP | 1 |
| Campbell, JE | 1 |
| Cafarelli, E | 1 |
| Adegoke, OA | 1 |
| Hawke, TJ | 1 |
| Riddell, MC | 1 |
1 other study available for xylazine and Autoimmune Diabetes
| Article | Year |
|---|---|
Impaired growth and force production in skeletal muscles of young partially pancreatectomized rats: a model of adolescent type 1 diabetic myopathy?
Topics: Adolescent; Analgesics; Animals; Diabetes Mellitus, Type 1; Disease Models, Animal; Humans; Ketamine | 2010 |